CAS: 138729-47-2; Eszopiclone

该化合物是一种主要用于治疗失眠症的非苯二氮杂卓镇静-苯丙胺药物,它属于被称为环球体的药物类别,具有增强伽马-氨基丁酸(GABA)作用的能力,这是一种促进睡眠的...

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

1-methyl-piperazine (S)-(+)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one 6-(5-chloropyridin-2-yl)-7-hydroxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one (+/-)-7-(2-chloromethyloxycarbonyloxy)-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one(S)-desmethylzopiclone hydr°Chloride (S)-zopiclone (R)-mandelate (-)-Zopiclone 17H17ClN6O4C17H17ClN6O4

合成工艺路线路线简述

  • 合成目标产物 Eszopiclone 主要起始原料 Zopiclone
  • (文献来源)合成步骤主要原料 Zopiclone
佐匹克隆 以36的收率获得右佐匹克隆
参考文献:Methods Of Making And Using N-Desmethylzopiclone
标题:Methods Of Making And Using N-Desmethylzopiclone
摘要:本发明涉及包含及使用外消旋n-去甲基唑吡克隆,光学纯(+)-N-去甲基唑吡克隆和光学纯(−)-N-去甲基唑吡克隆的组合物在哺乳动物的疾病和状况的治疗和预防方面的方法.本发明还涉及制备n-去甲基唑吡克隆,光学纯(+)-N-去甲基唑吡克隆和光学纯(−)-N-去甲基唑吡克隆的新方法.

海关参考信息

专利信息


专利号:US-2012177593-A1
优先权日:2009-07-20
标 题 :Synthesis of dendrimer conjugates
发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

专利号:US-10005720-B2
优先权日:2013-04-05
标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

专利号:US-2008015197-A1
优先权日:2006-06-26
标题 :Process for the preparatrion of zopiclone
发明人:MAINFELD ALEX; MENDELOVICI MARIOARA
权利人:MAINFELD ALEX; MENDELOVICI MARIOARA
摘要:Provided is a process for the preparation of zopiclone, an intermediate in the synthesis of eszopiclone.

专利号:US-7304069-B2
优先权日:2004-10-18
标题 :Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
发明人:ZOOK SCOTT E; HETTINGER DONALD
权利人:NEUROCRINE BIOSCIENCES INC
摘要:A novel hydrate form of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide (“Compound No. 1â€?) and processes related to the use thereof in the synthesis of a polymorphic form of Compound No. 1.

专利号:US-2015352230-A1
优先权日:2013-01-11
标 题:Synthesis and isolation of dendrimer based imaging systems
发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
权利人:UNIV MICHIGAN
摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

专利号:US-2012232225-A1
优先权日:2009-08-26
标 题:Synthesis and isolation of dendrimer systems
发明人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL
权利人:BAKER JR JAMES R; BANASZAK HOLL MARK M; MULLEN DOUGLAS GURNETT; ORR BRADFORD G; DESAI ANKUR; SANDER LEONARD M; WADDELL JACK NEEL; UNIV MICHIGAN
摘要:The present invention relates to novel methods of synthesis and isolation of dendrimer systems. In particular, the present invention is directed to novel dendrimer conjugates with defined and limited numbers of ligand conjugates and high levels of structural uniformity, methods of synthesizing the same, compositions comprising the conjugates, as well systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer) diagnosis and/or therapy, pain therapy, etc.)).
天津科创医药中间体技术生产力促进有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.scipharmacn.com
企业联系电话:022-60116533👤
📞天津科创医药中间体技术生产力促进有限公司 ⚠️参考联系方式
联系人:王经理
电话:022-60116533
手机:13207668525
传真:022-60979672
邮箱:saleskc@scipharmacn.com
通信地址: 天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
邮编: 300118
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:天津市华苑产业园区(环外)海泰发展六道6号海泰绿色产业基地
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
杭州鼎燕化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.dingyanchem.com
企业联系电话:18267553885👤
📞杭州鼎燕化工有限公司 ⚠️参考联系方式
联系人:林女士
电话:18267553885
手机:18267553885
传真:0571-87156470
邮箱:sales@dingyanchem.com
通信地址: 杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
邮编: 310018
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:杭州市江干区下沙19号大街571号下沙电子商务园4A601-602室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s00414-011-0597-y
摘要:Salomone A, Gerace E, Di Corcia D, Martra G, Petrarulo M, Vincenti M. Hair analysis of drugs involved in drug-facilitated sexual assault and detection of zolpidem in a suspected case. International Journal of Legal Medicine. 2011 Jul 13;126(3):451–9. doi: 10.1007/s00414-011-0597-y.
参考文献:10.2165/11591730-000000000-00000
摘要:Wallerstedt SM, Brunlöf G, Sundström A. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register. Drug Saf. 2011 Aug 01;34(8):669–82. doi: 10.2165/11591730-000000000-00000.
参考文献:10.1007/s00216-011-5187-9
摘要:Remane D, Meyer MR, Wissenbach DK, Maurer HH. Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs. Analytical and Bioanalytical Chemistry. 2011 Jul 21;401(4):1341. doi: 10.1007/s00216-011-5187-9.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知